JE
Jeffrey Engelman
Internal Medicine
Credentials: · ·
History
- 2002–2005
Hematology and Medical Oncology
1996–2000
Research
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling
Science · 2007 · First of 19 authors · 3,888 citations
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer
New England Journal of Medicine · 2010 · 3,649 citations
Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors
Science Translational Medicine · 2011 · Last of 22 authors · Corresponding · 2,891 citations
47 papers · 1 as a fellow
42 papers
39 papers
- MM
33 papers
32 papers
- JG
27 papers · 8 as a fellow
- AH
23 papers · 4 as a fellow
22 papers
